ClinicalTrials.Veeva

Menu

ECT Schizophrenia Serotonin Study

S

Sha'ar Menashe Mental Health Center

Status

Unknown

Conditions

Schizophrenia

Study type

Observational

Funder types

Other

Identifiers

NCT00278668
123.ctil

Details and patient eligibility

About

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Full description

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Enrollment

15 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).

Ages 18 -55 Men and/or women -

Exclusion criteria

  1. History of neurological disorders, active substance abuse in the previous 3 months.

  2. Estimated IQ less then 70.

  3. SSRIs treatment 4 weeks prior to the study.

  4. Any subject suffering from inflammatory fever disease will be excluded from the study.

Trial contacts and locations

0

Loading...

Central trial contact

Avi Peled, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems